News Daily News EuroCTO CASTLE: Prediction Model for CTO PCI Success Shows Good Discriminating Ability L.A. McKeown February 04, 2019
News Features Hopes Fade for a CV Indication for Canakinumab: What’s Next for the Inflammatory Hypothesis? Michael O'Riordan February 01, 2019
Presentation ISET 2019 The Economics of PVD: Current Costs and future Payment Models Presenter: Gary Ansel January 30, 2019
News Conference News WCC 2018 CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden Todd Neale December 06, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News AHA 2018 Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages Michael O'Riordan November 12, 2018
News Conference News TCT 2018 TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers Todd Neale September 22, 2018
News Daily News Good INR Control on Warfarin Doesn’t Necessarily Predict Future Success, Outcomes Todd Neale September 13, 2018
News Daily News In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check Caitlin E. Cox August 15, 2018
News Conference News The Structural Heart Disease Summit 2018 Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR? Shelley Wood June 21, 2018
News Daily News Similar Rate of Radial Artery Occlusion After Manual and Mechanical Compression Michael O'Riordan June 05, 2018
News Daily News Financial Burden of Hypertension Weighs Heavily on US Population Todd Neale May 30, 2018
News Daily News FDA’s Proposed Sodium Reduction Plan Could Have a Big Impact, Analysis Suggests Todd Neale April 11, 2018
News Daily News Skyrocketing Costs of CVD Will Be Amplified by Informal Caregiving: AHA Shelley Wood April 09, 2018
News Conference News ACC 2018 ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit Michael O'Riordan March 10, 2018
News Conference News ACC 2018 iFR Cheaper Than FFR Over Trajectory of 1 Year: DEFINE-FLAIR Analysis Caitlin E. Cox March 10, 2018
News Daily News Nonstatin Use and Expenditures Are Up Despite the Dearth of Evidence Supporting Efficacy Yael L. Maxwell January 29, 2018
News Conference News AHA 2017 ‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18 Michael O'Riordan November 15, 2017